Johnson & Johnson (JNJ) Investment Research Report: Analyzing Competitive Moats, Capital Allocation, and Structural Headwinds

Slide Deck Executive Summary Johnson & Johnson (JNJ) operates as a profoundly transformed entity in 2026, having shed its legacy consumer health division (Kenvue) to become a pure-play, diversified healthcare conglomerate focused strictly on Innovative Medicine (pharmaceuticals) and MedTech (medical devices). The fundamental investment debate surrounding the company centers on a critical tension: the historical […]